Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial

Author： Beasley C.M. Hamilton S.H. Crawford A.M. Dellva M.A. Tollefson G.D. Tran P.V. Blin O. Beuzen J.-N.

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.7, Iss.2, 1997-05, pp. : 125-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute and long-term results of the North American double-blind olanzapine trial

By Tran P.V. Beasley C.M. Tollefson G.D. Beuzen J.N. Dellva M.A. Sanger T.M. Paul S.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 347-348

Elsevier

Access to resources Recommend Favorite

Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial

By Cavazzoni P. Tanaka Y. Roychowdhury S.M. Breier A. Allison D.B.

European Neuropsychopharmacology, Vol. 13, Iss. 2, 2003-03 ,pp. : 81-85

Elsevier

Access to resources Recommend Favorite

Clinical and Economic Outcomes of Olanzapine Compared With Haloperidol for Schizophrenia: Results From a Randomised Clinical Trial

By Hamilton S.H.

PharmacoEconomics, Vol. 15, Iss. 5, 1999-05 ,pp. : 469-480

Adis International

Access to resources Recommend Favorite

Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder

By Harvey Philip Siu Cynthia Romano Steven

Psychopharmacology, Vol. 172, Iss. 3, 2004-03 ,pp. : 324-332

Springer Publishing Company

Access to resources Recommend Favorite

The Efficacy and Safety of Blonanserin Compared with Haloperidol in Acute-Phase Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Multicentre Study

By Garcia Esther

CNS Drugs, Vol. 23, Iss. 7, 2009-07 ,pp. : 615-625

Adis International

Access to resources Recommend Favorite